Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 0.8%.
The iShares Biotechnology ETF (IBB) climbed 1.7%.
In corporate news, Regenxbio (RGNX) shares jumped 19% after it said the US Food and Drug Administration has agreed on the next steps for a potential accelerated approval of Navsunli, its experimental gene therapy for Mucopolysaccharidosis II, following discussions related to its appeal of a complete response letter issued in February.